基金经理：
| 单位净值:0.3838 | 净值增长率:-6.18% | 净值增长率:-6.18% | 累计净值:0.3838 | 截止日期:2024/10/11 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:29.7亿元 | 风险等级:高风险 | 申购状态:不可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
天弘国证生物医药ETF(159859)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2024/6/30 | 2,601,810,000 | - | 2,620,060,000 | 2,611,720,000 | 100% |
| 2024/3/31 | 2,554,930,000 | - | 2,565,610,000 | 2,561,670,000 | 100% |
| 2023/12/31 | 3,022,120,000 | - | 3,033,960,000 | 3,027,960,000 | 100% |
| 2023/9/30 | 3,305,200,000 | - | 3,326,440,000 | 3,309,880,000 | 100% |
| 2023/6/30 | 2,915,080,000 | - | 2,924,700,000 | 2,919,780,000 | 100% |
| 2023/3/31 | 1,809,930,000 | - | 1,840,530,000 | 1,816,000,000 | 100% |
| 2022/12/31 | 1,473,580,000 | - | 1,487,480,000 | 1,477,310,000 | 100% |
| 2022/9/30 | 1,443,170,000 | - | 1,450,290,000 | 1,446,250,000 | 100% |
| 2022/6/30 | 1,246,750,000 | - | 1,253,320,000 | 1,246,910,000 | 100% |
| 2022/3/31 | 1,100,280,000 | - | 1,105,280,000 | 1,104,320,000 | 100% |
| 2021/12/31 | 1,195,860,000 | - | 1,206,050,000 | 1,202,840,000 | 99% |
| 2021/9/30 | 146,428,000 | - | 147,711,000 | 147,489,000 | 99% |
| 2021/6/30 | 23,742,200 | - | 252,851,000 | 229,141,000 | 10% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。